International Flavors & Fragrances has launched Omni-Bos PHY, a phytase enzyme for dairy cattle aimed at improving feed efficiency, nutrient utilization and producer profitability across key emerging regions. The animal nutrition product arrives as IFF shares trade at US$84.91, with a 30-day share price return of 4.83% and a 24.81% year-to-date gain, while total shareholder return stands at 37.06% over the past year and 32.41% over three years, against a 27.02% decline over five years. On the most followed narrative, IFF screens as 10% undervalued, with an estimated fair value of about $94.82 against the recent $84.91 share price, a case that leans on recent divestitures of commodity businesses including Pharma Solutions, Soy Crush, Concentrates and Lecithin, plus the ongoing strategic evaluation of the Food Ingredients segment. Management expects investments in R&D and capacity, especially in Health & Biosciences, Taste and Specialty Fragrance Ingredients, to accelerate revenue and profit growth beginning in 2026 and reaching full impact by 2027. A separate lens using the SWS DCF model points to a future cash flow value of $106.45 at today's $84.91 price, also flagging the stock as undervalued, though ongoing weakness in key markets and pressure in fragrance ingredients could derail the case.
International Flavors & Fragrances IncIFF launched Omni-Bos PHY, a new phytase enzyme product for dairy cattle improving feed efficiency and nutrient utilization.
OK Rusal MKPAO